^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Breast Cancer: SYSTEMIC THERAPY FOR ER- AND/OR PR-POSITIVE RECURRENT OR STAGE IV (M1) DISEASE...HER2-Negative and Postmenopausal or Premenopausal Receiving Ovarian Ablation or Suppression…Preferred Regimens…First-Line Therapy...Selective estrogen receptors modulator (tamoxifen or toremifene)…